TargetMol
Romidepsin is an intravenously administered histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous and peripheral T cell lymphomas.
More Information
Supplier Page
U 19963
50 mg
| 99.40%
TargetMol
U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.
More Information
Supplier Page
U 19963
25 mg
| 99.40%
TargetMol
U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.
More Information
Supplier Page
U 19963
10 mg
| 99.40%
TargetMol
U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.
More Information
Supplier Page
U 19963
100 mg
| 99.40%
TargetMol
U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.
More Information
Supplier Page
Temuterkib
5 mg
| Purity Not Available
TargetMol
LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.
More Information
Supplier Page
Temuterkib
2 mg
| Purity Not Available
TargetMol
LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.
More Information
Supplier Page
Temuterkib
25 mg
| Purity Not Available
TargetMol
LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.
More Information
Supplier Page
TargetMol
U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.
More Information
Supplier Page
TargetMol
Autophinib is a potent autophagy inhibitor with a novel chemotype with IC50 values of 90 and 40 nM for autophagy in starvation induced autophagy assay and rapamycin induced autophagy assay.
More Information
Supplier Page